Patient assistance
搜索文档
Regeneron Pharmaceuticals (NasdaqGS:REGN) 2025 Conference Transcript
2025-11-18 00:32
Regeneron Pharmaceuticals (NasdaqGS:REGN) 2025 Conference November 17, 2025 10:30 AM ET Company ParticipantsChristopher Fenimore - Senior Vice President CommercialRyan Crowe - Senior Vice President of Investor RelationsConference Call ParticipantsAkash Shah - Pharma and Biotech AnalystAkash ShahAre we good? All right. Awesome. Thanks so much, everyone. It's funny, I had a secondary investor, and it was his first time in London. He goes, "You know, it's not that crowded, and I think it's going to be OK." I t ...